These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mitochondrial complex I promotes kidney cancer metastasis. Bezwada D; Perelli L; Lesner NP; Cai L; Brooks B; Wu Z; Vu HS; Sondhi V; Cassidy DL; Kasitinon S; Kelekar S; Cai F; Aurora AB; Patrick M; Leach A; Ghandour R; Zhang Y; Do D; McDaniel P; Sudderth J; Dumesnil D; House S; Rosales T; Poole AM; Lotan Y; Woldu S; Bagrodia A; Meng X; Cadeddu JA; Mishra P; Garcia-Bermudez J; Pedrosa I; Kapur P; Courtney KD; Malloy CR; Genovese G; Margulis V; DeBerardinis RJ Nature; 2024 Sep; 633(8031):923-931. PubMed ID: 39143213 [TBL] [Abstract][Full Text] [Related]
3. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells. Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866 [TBL] [Abstract][Full Text] [Related]
4. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas. Zhang Q; Liu JH; Liu JL; Qi CT; Yan L; Chen Y; Yu Q BMC Cancer; 2019 Nov; 19(1):1044. PubMed ID: 31690270 [TBL] [Abstract][Full Text] [Related]
6. Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinoma. Minton DR; Fu L; Chen Q; Robinson BD; Gross SS; Nanus DM; Gudas LJ PLoS One; 2015; 10(4):e0120649. PubMed ID: 25830305 [TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide-dependent kinase 1-associated glycolysis is regulated by miR-409-3p in clear cell renal cell carcinoma. Wang Y; He Y; Bai H; Dang Y; Gao J; Lv P J Cell Biochem; 2019 Jan; 120(1):126-134. PubMed ID: 30218446 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial metabolism in primary and metastatic human kidney cancers. Bezwada D; Lesner NP; Brooks B; Vu HS; Wu Z; Cai L; Kasitinon S; Kelekar S; Cai F; Aurora AB; Patrick M; Leach A; Ghandour R; Zhang Y; Do D; Sudderth J; Dumesnil D; House S; Rosales T; Poole AM; Lotan Y; Woldu S; Bagrodia A; Meng X; Cadeddu JA; Mishra P; Pedrosa I; Kapur P; Courtney KD; Malloy CR; Margulis V; DeBerardinis RJ bioRxiv; 2023 Feb; ():. PubMed ID: 36798172 [TBL] [Abstract][Full Text] [Related]
9. Isotopomer analyses with the tricarboxylic acid cycle intermediates and exchanging metabolites from the rat kidney. Jin ES; Wen X; Malloy CR NMR Biomed; 2023 Oct; 36(10):e4994. PubMed ID: 37392148 [TBL] [Abstract][Full Text] [Related]
10. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma. Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827 [TBL] [Abstract][Full Text] [Related]
11. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma. Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555 [TBL] [Abstract][Full Text] [Related]
20. Expression of PGAM1 in renal clear cell carcinoma and its clinical significance. Li C; Shu F; Lei B; Lv D; Zhang S; Mao X Int J Clin Exp Pathol; 2015; 8(8):9410-5. PubMed ID: 26464696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]